Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: Case-control retrospective study

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Wu, Wan Chen ^a   Wang, Chih Yuan ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diabetes mellitus; Metabolic syndrome; Non alcoholic fatty pancreatic disease; Obesity; Trans abdominal ultrasonography

Indexed keywords

GLUCOSE; CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMEN; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY PANCREATIC DISEASE; PANCREAS DISEASE; POSTPRANDIAL STATE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; AGE DISTRIBUTION; BLOOD; BLOOD PRESSURE; DIABETES MELLITUS; ECHOGRAPHY; INTRAABDOMINAL FAT; OBESITY; OBESITY, ABDOMINAL; PANCREAS; PANCREATIC DISEASES;

AGE DISTRIBUTION; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; INTRA-ABDOMINAL FAT; METABOLIC SYNDROME X; OBESITY; OBESITY, ABDOMINAL; PANCREAS; PANCREATIC DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 84877842142     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-77     Document Type: Article

References (28)

1. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003, 144(12):5159-5165. 10.1210/en.2003-0870, 12960011.
2. Yin W, Liao D, Kusunoki M, Xi S, Tsutsumi K, Wang Z, Lian X, Koike T, Fan J, Yang Y. NO-1886 decreases ectopic lipid deposition and protects pancreatic beta cells in diet-induced diabetic swine. J Endocrinol 2004, 180(3):399-408. 10.1677/joe.0.1800399, 15012594.
3. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28(1):27-38.
4. Park BJ, Kim YJ, Kim DH, Kim W, Jung YJ, Yoon JH, Kim CY, Cho YM, Kim SH, Lee KB. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 2008, 23(6):900-907. 10.1111/j.1440-1746.2007.05212.x, 17995942.
5. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006, 91(11):4287-4294. 10.1210/jc.2006-1010, 16912127.
6. Ogilvie RF. The islands of Langerhans in 19 cases of obesity. J Pathol Bacteriol 1933, 37(3):473-481.
7. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 1994, 91(23):10878-10882. 10.1073/pnas.91.23.10878, 45129, 7971976.
8. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem 1996, 271(10):5633-5637. 10.1074/jbc.271.10.5633, 8621426.
9. Milburn JL, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, BeltrandelRio H, Newgard CB, Johnson JH, Unger RH. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995, 270(3):1295-1299. 10.1074/jbc.270.3.1295, 7836394.
10. Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G, Mehta G, Chuttani R, Kane R, Pleskow D. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 2011, 73(5):987-993. 10.1016/j.gie.2011.01.015, 21521567.
11. Al-Haddad M, Khashab M, Zyromski N, Pungpapong S, Wallace MB, Scolapio J, Woodward T, Noh K, Raimondo M. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 2009, 38(6):672-675. 10.1097/MPA.0b013e3181a9d5af, 19506531.
12. Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F, Claussen CD, Stefan N, Haring HU, Fritsche A. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010, 26(3):200-205. 10.1002/dmrr.1073, 20225188.
13. Lee JS, Kim SH, Jun DW, Han JH, Jang EC, Park JY, Son BK, Jo YJ, Park YS, Kim YS. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009, 15(15):1869-1875. 10.3748/wjg.15.1869, 2670415, 19370785.
14. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009, 94(10):4070-4076. 10.1210/jc.2009-0584, 2758729, 19773401.
15. Sijens PE, Edens MA, Bakker SJ, Stolk RP. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 2010, 16(16):1993-1998. 10.3748/wjg.v16.i16.1993, 2860076, 20419836.
16. Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK, Mari A, Heine RJ, Diamant M. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007, 30(11):2916-2921. 10.2337/dc07-0326, 17666465.
17. Choi CW, Kim GH, Kang DH, Kim HW, Kim DU, Heo J, Song GA, Park do Y, Kim S. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World J Gastroenterol 2010, 16(34):4329-4334. 10.3748/wjg.v16.i34.4329, 2937114, 20818817.
18. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A 1978, 86A(5):367-373.
19. Alexander Tenenbaum EZF. "The metabolic syndrome... is dead": These reports are an exaggeration. Cardiovasc Diabetol 2011, 10(1):4. 10.1186/1475-2840-10-4, 3033797, 21232147.
20. Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA, Butler PC. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007, 20(8):933-942. 10.1002/ca.20543, 2680737, 17879305.
21. Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, Pitt HA. Nonalcohlic fatty pancreas disease. HPB (Oxford) 2007, 9(4):312-318.
22. Lee IT, Chiu YF, Hwu CM, He CT, Chiang FT, Lin YC, Assimes T, Curb JD, Sheu WH. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study. Cardiovasc Diabetol 2012, 11:43. 10.1186/1475-2840-11-43, 3476431, 22537054.
23. van Geenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 2010, 39(8):1185-1190. 10.1097/MPA.0b013e3181f6fce2, 20871475.
24. Maruyama K, Takahashi H, Okuyama K, Yokoyama A, Nakamura Y, Kobayashi Y, Ishii H. Low serum amylase levels in drinking alcoholics. Alcohol Clin Exp Res 2003, 27(8 Suppl):16S-21S.
25. Dominguez-Munoz JE, Pieramico O, Buchler M, Malfertheiner P. Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pancreatitis. Digestion 1993, 54(4):231-236. 10.1159/000201042, 7694884.
26. Trimble ER, Bruzzone R, Belin D. Insulin resistance is accompanied by impairment of amylase-gene expression in the exocrine pancreas of the obese Zucker rat. Biochem J 1986, 237(3):807-812. 1147060, 2432875.
27. Schneeman BO, Inman MD, Stern JS. Pancreatic enzyme activity in obese and lean Zucker rats: a developmental study. J Nutr 1983, 113(4):921-925.
28. Nakajima K, Nemoto T, Muneyuki T, Kakei M, Fuchigami H, Munakata H. Low serum amylase in association with metabolic syndrome and diabetes: A community-based study. Cardiovasc Diabetol 2011, 10:34. 10.1186/1475-2840-10-34, 3102610, 21496338.